Trials / Unknown
UnknownNCT04087863
Administration for Placebo Group and Evalution the Safety and Efficacy in Atopic Dermatitis Patients
A Multi-center, Open, Single-arm Clinical Trial to Evaluate the Safety and Efficacy of FURESTEM-AD Inj. in Patients With Moderate to Severe Chronic Atopic Dermatitis Who Participated in a Placebo Group in K0102 Clinical Trial: 2nd Extension Study of K0102
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 99 (estimated)
- Sponsor
- Kang Stem Biotech Co., Ltd. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
A Multi-center, Open, Single-arm Clinical Trial to Evaluate the Safety and Efficacy of FURESTEM-AD inj. in Patients with Moderate to Severe Chronic Atopic Dermatitis Who Participated in a Placebo Group in K0102 Clinical Trial: 2nd Extension Study of K0102
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Not applicable(observational study) | Not applicable(observational study) |
Timeline
- Start date
- 2019-08-29
- Primary completion
- 2022-12-31
- Completion
- 2024-12-31
- First posted
- 2019-09-12
- Last updated
- 2019-09-12
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04087863. Inclusion in this directory is not an endorsement.